Cardiovascular Pathology
Volume 19, Issue 3 , Pages 158-164 , May 2010

Activation of the ubiquitin proteolytic pathway in human septic heart and diaphragm

Received 29 July 2008 ,Revised 30 November 2008 ,Accepted 14 January 2009.

References 

  1. Rabuel C, Mebazaa A. Septic shock: a heart story since the 1960s. Intensive Care Med. 2006;32:799–807
  2. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471–1477
  3. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483–490
  4. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic serum. J Exp Med. 1996;183:949–958
  5. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387–389
  6. Kelly R Balligand J Smith T. Nitric oxide and cardiac function. Circ Res. 1996;79:363–380
  7. Mebazaa A, De Keulenaer GW, Paqueron X, Andries LJ, Ratajczak P, Lanone S, et al. Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide. Circulation. 2001;104:3137–3144
  8. Tavernier B, Li JM, El-Omar MM, Lanone S, Yang ZK, Trayer IP, et al. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J. 2001;15:294–296
  9. Hussain SN, Simkus G, Roussos C. Respiratory muscle fatigue: a cause of ventilatory failure in septic shock. J Appl Physiol. 1985;58:2033–2040
  10. Leon A, Boczkowski J, Dureuil B, Desmonts JM, Aubier M. Effects of endotoxic shock on diaphragmatic function in mechanically ventilated rats. J Appl Physiol. 1992;72:1466–1472
  11. Callahan LA, Nethery D, Stofan D, DiMarco A, Supinski G. Free radical-induced contractile protein dysfunction in endotoxin-induced sepsis. Am J Respir Cell Mol Biol. 2001;24:210–217
  12. Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 2000;162:2308–2315
  13. Rabuel C, Renaud E, Brealey D, Ratajczak P, Damy T, Alves A, et al. Human septic myopathy: induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology. 2004;101:583–590
  14. Corda S, Mebazaa A, Tavernier B, Ayed MB, Payen D. Paracrine regulation of cardiac myocytes in normal and septic heart. J Crit Care. 1998;13:39–47
  15. Weber CM, Eke BC, Maines MD. Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J Neurochem. 1994;63:953–962
  16. Tiao G, Fagan J, Roegner V, Lieberman M, Wang JJ, Fischer JE, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest. 1996;97:339–348
  17. Barreiro E, Comtois AS, Gea J, Laubach VE, Hussain SN. Protein tyrosine nitration in the ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol. 2002;26:438–446
  18. Thoenes M, Förstermann U, Tracey WR, Bleese NM, Nüssler AK, Scholz H, et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol. 1996;28:165–169
  19. Khadour FH, Panas D, Ferdinandy P, Schulze C, Csont T, Lalu MM, et al. Enhanced NO and superoxide gneration in dysfunctional hearts from endotoxemic rats. Am J Physiol. 2002;283:H1108–H1115
  20. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, et al. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol. 2004;43:2348–2358
  21. Lanone S, Manivet P, Callebert J, Launay JM, Payen D, Aubier M, et al. Inducible nitric oxide synthase (NOS2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity. Biochem J. 2002;366:399–404
  22. Patterson C, Ike C, Willis PW, Stouffer GA, Willis MS. The bitter end; the ubiquitin-proteasome system and cardiac dysfunction. Circulation. 2007;115:1456–1463
  23. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683–693
  24. Supinski G, Stofan D, Callahan LA, Nethery D, Nosek TM, DiMarco A. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm. J Appl Physiol. 1999;87:783–791
  25. Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, Enns D, et al. Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med. 2002;166:1369–1374
  26. Rossi MA, Celes MR, Prado CM, Saggioro FP. Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock. 2007;27:10–18
  27. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997;99:163–168

 Financial support: Ministère de l’Enseignement Supérieur et de la Recherche (EA 322 for D.P.).

PII: S1054-8807(09)00005-2

doi: 10.1016/j.carpath.2009.01.002

Cardiovascular Pathology
Volume 19, Issue 3 , Pages 158-164 , May 2010

Article Tools

* Image Usage & Resolution